Multimarker model for non-invasive assessment of variceal bleeding in chronic hepatitis C cirrhotic patients

Table 8 Relationship between fundal varices and different parameters in group I and group II, mean ± SD

Parameter	Group I1		P value2	Group II1		P value2
	FV present	FV absent		FV present	FV absent
TSH (μIU/mL)	1.62 ± 2.51	1.06 ± 0.77	0.35	2.65 ± 3.23	1.23 ± 1.44	0.45
FT3 (pmol/L)	2.40 ± 0.93	2.72 ± 0.91	0.39	3.01 ± 1.38	2.51 ± 0.91	0.34
FT4 (pmol/L)	13.82 ± 1.35	14.56 ± 3.29	0.39	17.45 ± 6.72	12.59 ± 5.13	0.09
PLT (× 103/μL)	100.56 ± 37.12	96.55 ± 36.06	0.78	100.75 ± 30.61	126.29 ± 53.64	0.36
INR	1.46 ± 0.12	1.48 ± 0.33	0.84	1.74 ± 0.62	1.35 ± 0.31	0.40
Spleen size (cm)	17.69 ± 1.79	16.65 ± 2.02	0.19	15.07 ± 2.33	13.96 ± 1.80	0.27
PVD (mm)	13.66 ± 1.67	13.19 ± 2.21	0.58	12.38 ± 1.60	11.89 ± 2.08	0.66

¹Comparison of clinical parameters between patients with and without fundal varices in group I and group II.

²The P-value represents statistical significance based on the t-test (or Mann-Whitney U test if data were non-parametric). A P-value < 0.05 was considered statistically significant.

FV: Fundal varices; PLT: Platelet count; INR: International normalized ratio; TSH: Thyroid-stimulating hormone; FT3: Free triiodothyronine; FT4: Free thyroxine; PVD: Portal vein diameter.